mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.04 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.04 |
mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.04 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.04 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.094 |
0.04 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.05 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.05 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.05 |